Ferreira Melo, S., Nondonfaz, A., Aqil, A., Pierrard, A., Hulin, A., Delierneux, C., Ditkowski, B., Gustin, M., Legrand, M., Tullemans, B. M. E., Brouns, S. L. N., Nchimi Longang, A., Carrus, R., Dejosé, A., Heemskerk, J. W. M., Kuijpers, M. J. E., Ritter, J., Steinseifer, U., Clauser, J. C., ... Oury, C. (2024). Design, manufacturing and testing of a green non-isocyanate polyurethane prosthetic heart valve. Biomaterials Science. doi:10.1039/d3bm01911j Peer Reviewed verified by ORBi |
Donis, N., Jiang, Z., D'Emal, C., Hulin, A., Debuisson, M., Dulgheru, R. E., Nguyen, M.-L., Postolache, A., LALLEMAND, F., COUCKE, P., Martinive, P., Herzog, M., Pamart, D., Terrell, J., Pincemail, J., Drion, P., DELVENNE, P., Nchimi Longang, A., LANCELLOTTI, P., & Oury, C. (28 February 2022). Differential Biological Effects of Dietary Lipids and Irradiation on the Aorta, Aortic Valve, and the Mitral Valve. Frontiers in Cardiovascular Medicine, 9, 1-16. doi:10.3389/fcvm.2022.839720 Peer Reviewed verified by ORBi |
Oury, C., MARECHAL, P., Donis, N., Hulin, A., Hego, A., TRIDETTI, J., Nguyen, M.-L., DULGHERU, R. E., Fillet, M., Nchimi Longang, A., & Lancellotti, P. (2020). Dexfenfluramine and Pergolide Cause Heart Valve Disease via Valve Metabolic Reprogramming and Ongoing Matrix Remodeling. International Journal of Molecular Sciences, 21 (11). doi:10.3390/ijms21114003 Peer Reviewed verified by ORBi |
Kim, A. J., Xu, N., Umeyama, K., Hulin, A., Ponny, S. R., Vagnozzi, R. J., Green, E. A., Hanson, P., McManus, B. M., Nagashima, H., & Yutzey, K. E. (2020). Deficiency of Circulating Monocytes Ameliorates the Progression of Myxomatous Valve Degeneration in Marfan Syndrome. Circulation, 132-146. doi:10.1161/CIRCULATIONAHA.119.042391 Peer Reviewed verified by ORBi |
Donis, N., D'Emal, C., Hulin, A., Gustin, M., DULGHERU, R. E., LANCELLOTTI, P., & Oury, C. (22 November 2019). Platelets and aortic valve calcification: insights from a rabbit model and from patients with severe aortic stenosis [Paper presentation]. Belgian Working Group of Basic Research in Cardiology, Belgium. |
Blomme, B.* , Deroanne, C.* , Hulin, A., Lambert, C., Defraigne, J.-O., Nusgens, B., Radermecker, M., & Colige, A. (20 August 2019). Mechanical strain induces a pro-fibrotic phenotype in human mitral valvular interstitial cells through RhoC/ROCK/MRTF-A and Erk1/2 signaling pathways. Journal of Molecular and Cellular Cardiology, 135, 149-159. doi:10.1016/j.yjmcc.2019.08.008 Peer Reviewed verified by ORBi * These authors have contributed equally to this work. |
Hulin, A., Hortells, L., Gomez-Stallons, M. V., O'Donnell, A., Chetal, K., Adam, M., Lancellotti, P., Oury, C., Potter, S. S., Salomonis, N., & Yutzey, K. E. (2019). Maturation of heart valve cell populations during postnatal remodeling. Development (Cambridge, England), 146 (12). doi:10.1242/dev.173047 Peer reviewed |
Hulin, A., Hego, A., Lancellotti, P., & Oury, C. (2018). Advances in Pathophysiology of Calcific Aortic Valve Disease Propose Novel Molecular Therapeutic Targets. Frontiers in Cardiovascular Medicine, 5, 21. doi:10.3389/fcvm.2018.00021 Peer Reviewed verified by ORBi |
Hulin, A., Potter, S., Kim, A., DeFalco, T., & Yutzey, K. E. (2017). Contribution of macrophages to myxomatous valve disease [Poster presentation]. Experimental Biology. |
Hulin, A., Moore, V., James, J. M., & Yutzey, K. E. (2017). Loss of Axin2 results in impaired heart valve maturation and subsequent myxomatous valve disease. Cardiovascular Research, 113 (1), 40-51. doi:10.1093/cvr/cvw229 Peer Reviewed verified by ORBi |
Hulin, A., & Yutzey, K. (2016). Loss of Axin2 leads to Myxomatous Valve Disease [Poster presentation]. Experimental Biology. |
Deroyer, C., Magne, J., Moonen, M., Le Goff, C., Dupont, L., Hulin, A., Radermecker, M., Colige, A., Cavalier, E., Kolh, P., Pierard, L., LANCELLOTTI, P., Merville, M.-P., & Fillet, M. (2015). New biomarkers for primary mitral regurgitation. Clinical Proteomics, 12, 25. doi:10.1186/s12014-015-9097-2 Peer Reviewed verified by ORBi |
Hulin, A., Alfieri, C. M., & Yutzey, K. E. (2015). Loss of axin2 in murine aortic valves leads to myxomatous disease [Poster presentation]. Experimental Biology. |
Fang, M., Alfieri, C. M., Hulin, A., Conway, S. J., & Yutzey, K. E. (2014). Loss of beta-catenin promotes chondrogenic differentiation of aortic valve interstitial cells. Arteriosclerosis, Thrombosis and Vascular Biology, 34 (12), 2601-8. doi:10.1161/ATVBAHA.114.304579 Peer Reviewed verified by ORBi |
Hulin, A., Cheek, J. D., Alfieri, C. M., Hinton, R., Colige, A., & Yutzey, K. (2014). Chondrogenic Pathways Involved In The Development of Myxomatous Valve Disease [Poster presentation]. Biennal Heart Valve Biology and Tissue Engineering Meeting. |
Barnette, D., Hulin, A., Ahmed, I., Colige, A., Azhar, M., & LINCOLN, J. (December 2013). Tgfbeta-Smad and MAPK signaling mediate scleraxis and proteoglycan expression in heart valves. Journal of Molecular and Cellular Cardiology, 65, 137-146. doi:10.1016/j.yjmcc.2013.10.007 Peer Reviewed verified by ORBi |
Hulin, A., Deroanne, C., Lambert, C., Defraigne, J.-O., Nusgens, B., RADERMECKER, M., & Colige, A. (2013). Emerging pathogenic mechanisms in human myxomatous mitral valve: lessons from past and novel data. Cardiovascular Pathology, 22 (4), 245-250. doi:10.1016/j.carpath.2012.11.001 Peer Reviewed verified by ORBi |
Hulin, A. (2012). Etude des mécanismes pathogéniques impliqués dans la dégénérescence myxoïde de la valve mitrale [Doctoral thesis, Université de Liège]. ORBi-University of Liège. https://orbi.uliege.be/handle/2268/315018 |
Hulin, A., Deroanne, C., Lambert, C., Dumont, B., Castronovo, V., Defraigne, J.-O., Nusgens, B., RADERMECKER, M., & Colige, A. (27 January 2012). Metallothionein-dependent up-regulation of TGF-B2 participates in the remodelling of the myxomatous mitral valve. Cardiovascular Research, 93 (3), 480-9. Peer Reviewed verified by ORBi |
Hulin, A. (2012). Etude des mécanismes pathogéniques impliqués dans la dégénérescence myxoïde de la valve mitrale [Doctoral thesis, ULiège - Université de Liège]. ORBi-University of Liège. https://orbi.uliege.be/handle/2268/211237 |
Hulin, A., Lambert, C., Deroanne, C., Defraigne, J.-O., Nusgens, B., Colige, A., & RADERMECKER, M. (2011). Reduced expression of metallothioneins in myxomatous mitral valve prolapse andTGF-B2 signaling [Poster presentation]. Biennal Meeting of the Society for Heart Valve Disease, Barcelone, Spain. |
Radermecker, M., Boulanger, K., Hulin, A., Lambert, C., Limet, R., Lapière, C., & Nusgens, B. (2008). L'insuffisance mitrale par degenerescence myxoide: aspect biochimique et considerations physiopathologiques. Revue Médicale de Liège, 63 (4), 187-92. Peer reviewed |